"All three types of myasthenia gravis, based on antibody status, can have similar symptoms," said Henry Kaminski, MD, of George Washington University in Washington, D.C. "Most patients have droopy ...

Spotlight On > gMG Myasthenia Gravis Exacerbations — Emerging treatments focus on more precise immune modulation by Paul Smyth, MD, Contributing Writer, MedPage Today March 7, 2025 ...

References 1. Jin L, He D, Zend Q, et al.Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study. Ther Adv Neurol Disord. 2024;17:17562864241309431. doi:10.1177 ...

FOR many years it has been recognized that myasthenia gravis is associated, in a high percentage of cases, with structural abnormalities of the thymus. 1 Many patients, especially the younger ones ...

The medication blocks some actions of the complement system, which is an immune mechanism that plays a role in myasthenia gravis. A person will receive the treatment intravenously weekly for 4 ...

Current myasthenia gravis treatments and those under development could help treat the autoimmune disorder's symptoms, leading to partial or complete remission. Learn more.

Phase 3 AURORA trial on track to commence in 1H2025; Primary endpoint to assess proportion of Descartes-08-treated participants with myasthenia gravis demonstrating an MG-ADL improvement of ≥3 points ...

Treatments for myasthenia gravis include medications to help control and prevent symptoms related to muscle weakness and therapies during a myasthenic crisis (when symptoms worsen). Surgical removal ...

A new genetic analysis of patients with thymoma-associated myasthenia gravis (THYM-MG) has revealed potential biomarkers associated with follicular helper T (Tfh) cells and B cells, as well as ...

Hypoxia-inducible factor 1 (HIF-1) could play a key role in the pathogenesis of thymoma-associated myasthenia gravis (MG) by generating increased T helper 17 (T17) activity and decreasing regulatory T ...

A small proportion of patients with myasthenia gravis (MG) have alopecia and taste disorders, according to a new study published in the journal BMC Neurology. “Clinicians should be aware of the ...